Effects of Rivastigmine on reactivity based on the cholinesterase polymorphism in Alzheimer's patients
Not Applicable
- Conditions
- dementia
- Registration Number
- JPRN-UMIN000052878
- Lead Sponsor
- Kobe University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 203
Inclusion Criteria
Not provided
Exclusion Criteria
Those with a Mini-Mental State Examination (MMSE)11 score <24 and those already receiving public long-term care were excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The amount of change in cognitive function (composite score) from the time of enrollment to 18 months later. The composite score is calculated from the Z-scores of the MMSE, FCSRT, logical memory, DSST, TMT, counting, and word recall tasks.
- Secondary Outcome Measures
Name Time Method